CAS: 222631-44-9 - 3,4-Pyrrolidinediol,2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)-, hydrochloride(1:1), (2S,3S,4R,5R)-
Fórmula:C11H15N5O3・ClH
InChI:InChI=1S/C11H15N5O3.ClH/c12-11-8-6(14-3-15-11)4(1-13-8)7-10(19)9(18)5(2-17)16-7;/h1,3,5,7,9-10,13,16-19H,2H2,(H2,12,14,15);1H/t5-,7+,9-,10+;/m1./s1
Chave InChI:InChIKey=PCCHVYNGFMEGIG-QPAIBFMUSA-N
SMILES:Cl.OCC1NC(C2=CNC=3C(=NC=NC32)N)C(O)C1O
- Sinónimos:
- 3,4-Pyrrolidinediol, 2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)-, monohydrochloride, (2S,3S,4R,5R)-
- 3,4-Pyrrolidinediol,2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)-,monohydrochloride, (2S,3S,4R,5R)- (9CI)
- Bcx 4430
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Galidesivir DiHCl REF: 4Z-G-195001CAS: | - - - | A consultar | Qua 11 Dez 24 | |
BCX 4430 REF: TR-B119190CAS: 222631-44-9 | - - - | 46.850,00 € | Ter 21 Jan 25 | |
BCX 4430 hydrochloride REF: 3D-NB58350CAS: 222631-44-9 | Min. 95% | A consultar | Ter 21 Jan 25 | |
Galidesivir hydrochloride REF: TM-T10491LCAS: 222631-44-9 | 98% | 1.818,00 €~3.810,00 € | Ter 11 Fev 25 |
Galidesivir DiHCl
Ref: 4Z-G-195001
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
BCX 4430
Produto ControladoRef: TR-B119190
10mg | 46.850,00 € |
BCX 4430 hydrochloride
Ref: 3D-NB58350
5mg | A consultar |
Galidesivir hydrochloride
Ref: TM-T10491L
25mg | 1.818,00 € | ||
50mg | 2.376,00 € | ||
100mg | 3.810,00 € |